Fig. 1 · Structure
Documents & Downloads
UR-3216
GPIIb/IIIa Antagonist
UR-3216 is a selective, orally active antagonist of the GPIIb/IIIa receptor, a key regulator in platelet aggregation. By inhibiting this receptor, UR-3216 demonstrates potential in modulating platelet activity, making it valuable for research in cardiovascular diseases. Its unique properties enable exploration of therapeutic strategies targeting thrombosis and related vascular disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 220386-65-2 |
| Applications | GPIIb/IIIa Antagonist |
| Formula | C27H29N7O7 |
| Molecular Weight | 563.56 |
| SMILES | O=C(CN1N=C2C(CN(CC2)C([C@H](CC3=CC=C(C=C3)[N+]([O-])=O)NC(C4=CC=C(C=C4)/C(N)=N/O)=O)=O)=C1)OCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.